edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Sequana Medical — 3 videos in collection
Based in Belgium, Sequana Medical develops and commercialises products to treat diuretic-resistant fluid overload, a frequent complication of liver disease and heart failure. Its proprietary alfapump and DSR approaches aim to provide significant clinical and quality-of-life benefits in these fluid overload conditions.
In this interview, CEO Ian Crosbie describes how the alfapump may provide material benefits for patients with recurrent and refractory ascites as shown in pivotal data from its POSEIDON North American registration study, with US market approval projected before the end of 2024. Crosbie highlights the promising results shown so far for its DSR 2.0 product in patients with persistent congestion due to heart failure, including from the recent non-randomised cohort of its US MOJAVE Phase I/IIa study, and he discusses the next steps ahead for this programme.
Get access to the very latest content matched to your personal investment style.